-Ideally Performed Before PhIII or Reg Campaigns; Reduce PMI

-Quality Improvement

-Plant Fitness Assessment

Study the formation, fate, and purge of impurities from the RSM synthesis, and establish RSM specs based on the purge studies of these impurities in downstream processes.

Comprehensive process characterization via DoE studies or OVAT studies, including FMEA, probability, impact, detectability, PAR, and NOR.

Porton provides innovative drug introduction/license out services for global customers. These projects include innovative drugs such as small molecules from preclinical to commercial stages

The introduction of projects of different stages, molecular types, and indications can meet the diverse needs of global customers, and Porton‘s professional scientists and business development team will help customers improve the development speed of projects, enrich R&D pipelines, and expand product portfolios. In order to fully meet the different needs of global companies, Porton proposes a cooperation business model, reducing the risk of introduction and achieving mutual benefit and win-win results.

R&D in Commercial Campaign:

- Cost saving, time saving, and EHS purposes (such as reducing PMI) and troubleshooting.

- Based on the current process, optimize the process to improve yield and efficiency (such as replacing solvents, simplifying work-up, recycling materials, and other methods).

- 2nd generation process R&D.

We manage the product lifecycle from three different aspects:

- Continuous Cost Improvement

- Sustainable Supply Chain Management

- Capacity Planning